GSK

2,038

-1.74%↓

STJ

1,301

+0.04%↑

HIK

1,221

+0.49%↑

GSK

2,038

-1.74%↓

STJ

1,301

+0.04%↑

HIK

1,221

+0.49%↑

GSK

2,038

-1.74%↓

STJ

1,301

+0.04%↑

HIK

1,221

+0.49%↑

GSK

2,038

-1.74%↓

STJ

1,301

+0.04%↑

HIK

1,221

+0.49%↑

GSK

2,038

-1.74%↓

STJ

1,301

+0.04%↑

HIK

1,221

+0.49%↑

Search

Haleon PLC

Uždarymo kaina

SektoriusSveikatos priežiūra

376.7 -1.13

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

372.2

Max

381.1

Pagrindiniai rodikliai

By Trading Economics

Pajamos

403M

Pardavimai

2.7B

P/E

Sektoriaus vid.

22.147

66.845

Pelnas, tenkantis vienai akcijai

0.044

Dividendų pajamingumas

1.8

Pelno marža

14.708

Darbuotojai

24,561

EBITDA

697M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+12.3% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

1.80%

2.25%

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

34B

Ankstesnė atidarymo kaina

377.83

Ankstesnė uždarymo kaina

376.7

Naujienos nuotaikos

By Acuity

50%

50%

154 / 351 reitingas Healthcare

Haleon PLC Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-02-25 07:55; UTC

Uždarbis

Panadol Maker Haleon Reports Revenue Slowdown Amid Weak Cold-And-Flu Season

2025-10-30 07:52; UTC

Uždarbis

Haleon's Oral Health Products Drive Revenue Uptick

2025-07-31 08:02; UTC

Uždarbis
Pagrindinės rinkos jėgos

Haleon Shares Fall on Cut to Organic Revenue Guidance

2025-07-31 07:03; UTC

Uždarbis

Haleon Raises 2025 Profit Guidance, Cuts Revenue Growth Targets

2026-02-25 07:18; UTC

Uždarbis

Haleon 4Q Organic Revenue Growth 2.1%

2026-02-25 07:17; UTC

Uždarbis

Haleon: GBP500M Allocated to Share Buybacks in 2026

2026-02-25 07:16; UTC

Uždarbis

Haleon Sees 2026 High Single Digit Adj. Operating Profit Growth at Constant Currency

2026-02-25 07:15; UTC

Uždarbis

Haleon Sees 2026 Organic Revenue Growth of 3% to 5%

2026-02-25 07:06; UTC

Uždarbis

Haleon Declares Final Dividend of 4.9p

2026-02-25 07:05; UTC

Uždarbis

Haleon 2025 Net Pft GBP1.67B

2026-02-25 07:05; UTC

Uždarbis

Haleon 2025 Pretax Pft GBP2.15B

2026-02-25 07:04; UTC

Uždarbis

Analysts Saw Haleon 2025 Adj Oper Pft at GBP2.46B

2026-02-25 07:04; UTC

Uždarbis

Analysts Saw Haleon 2025 Adj Oper Pft Margin at 22.3%

2026-02-25 07:04; UTC

Uždarbis

Analysts Saw Haleon 2025 Organic Revenue Growth at 3.4%

2026-02-25 07:04; UTC

Uždarbis

Analysts Saw Haleon 2025 Rev at GBP11.03B

2026-02-25 07:04; UTC

Uždarbis

Haleon 2025 Adj. Operating Pft Margin 22.9%

2026-02-25 07:04; UTC

Uždarbis

Haleon 2025 Adj. Operating Pft GBP2.53B

2026-02-25 07:03; UTC

Uždarbis

Haleon 2025 Oper Pft GBP2.41B

2026-02-25 07:03; UTC

Uždarbis

Haleon 2025 Rev GBP11.03B

2026-02-25 07:00; UTC

Uždarbis

Haleon 2025 Organic Revenue Growth Was 3%

2025-10-30 10:10; UTC

Rinkos pokalbiai
Uždarbis

Haleon Clears a Lowered Bar -- Market Talk

2025-10-30 09:57; UTC

Rinkos pokalbiai
Uždarbis

Haleon's U.S. Growth Fueled by Restocking, Not Demand -- Market Talk

2025-10-30 07:04; UTC

Uždarbis

Analysts Saw Haleon 3Q Organic Revenue Growth at 3.3%

2025-10-30 07:04; UTC

Uždarbis

Haleon 3Q Organic Revenue Up 3.4%

2025-10-30 07:03; UTC

Uždarbis

Analysts Saw Haleon 3Q Revenue at GBP2.78B

2025-10-30 07:03; UTC

Uždarbis

Haleon 3Q Rev GBP2.80B

2025-10-30 07:02; UTC

Uždarbis

Haleon Had Seen High-Single-Digit Organic Operating Profit Growth in 2025

2025-10-30 07:02; UTC

Uždarbis

Haleon Saw 2025 Organic Revenue Growth at Around 3.5%

2025-10-30 07:01; UTC

Uždarbis

Haleon Backs 2025 View

2025-07-31 06:14; UTC

Uždarbis

Analysts Saw Haleon 1H Adjusted PBT at GBP1.10B

Akcijų palyginimas

Kainos pokytis

Haleon PLC Prognozė

Kainos tikslas

By TipRanks

12.3% į viršų

12 mėnesių prognozė

Vidutinis 434.36 GBX  12.3%

Aukščiausias 510 GBX

Žemiausias 335 GBX

Remiantis 11 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Haleon PLC kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

11 ratings

9

Pirkti

1

Laikyti

1

Parduoti

Rinkos nuotaikos

By Acuity

154 / 351 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Haleon PLC

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also offers various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.
help-icon Live chat